Previous studies have shown that PD1 can become an important target for immunotherapy of PC by changing the tumor immune microenvironment 42, 43, and PD1 is closely related to epithelial-mesenchymal transition-related proteins in PC 44. Here, PDCD1 is linked to pachyonychia congenita.